Insights into the Risk Factors and Outcomes of Post-COVID-19 Syndrome—Results from a Retrospective, Cross-Sectional Study in Romania DOI Creative Commons
Ioana Bejan, Corneliu Petru Popescu, Simona Ruță

et al.

Life, Journal Year: 2024, Volume and Issue: 14(11), P. 1519 - 1519

Published: Nov. 20, 2024

Post-Coronavirus Disease 2019 (post-COVID-19) syndrome represents a cluster of persistent symptoms following Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection that can severely affect quality life. The pathogenic mechanisms and epidemiology in different regions are still under evaluation. To assess the outcomes post-COVID-19 syndrome, we performed questionnaire-based, cross-sectional study previously infected individuals. Out 549 respondents, (male:female ratio: 0.32), 29.5% had at 3 months, 23.5% 6 18.3% 12 months after initial infection. most common included fatigue (8.7%), sleep disturbances (7.1%), cognitive impairment (6.4%). risk developing increased for those with more acute phase (OR 4.24,

Language: Английский

Variability in Arterial Stiffness and Vascular Endothelial Function After COVID-19 During 1.5 Years of Follow-Up—Systematic Review and Meta-Analysis DOI Creative Commons
Danuta Łoboda, Krzysztof S. Gołba, Piotr Jerzy Gurowiec

et al.

Life, Journal Year: 2025, Volume and Issue: 15(4), P. 520 - 520

Published: March 21, 2025

Increasing long-term observations suggest that coronavirus disease 2019 (COVID-19) vasculopathy may persist even 1.5 years after the acute phase, potentially accelerating development of atherosclerotic cardiovascular diseases. This study systematically reviewed variability brachial flow-mediated dilation (FMD) and carotid-femoral pulse wave velocity (cfPWV) from phase COVID-19 through 16 months follow-up (F/U). Databases including PubMed, Web Science, MEDLINE, Embase were screened for a meta-analysis without language or date restrictions (PROSPERO reference CRD42025642888, last search conducted on 1 February 2025). The quality included studies was assessed using Newcastle–Ottawa Quality Scale. We considered all (interventional pre-post studies, prospective observational randomized, non-randomized trials) FMD cfPWV in adults (aged ≥ 18 years) with laboratory-confirmed compared non-COVID-19 controls changes these parameters during F/U. Twenty-one reported differences FMD, examined between patients control groups various stages: acute/subacute (≤30 days onset), early (>30–90 days), mid-term (>90–180 late (>180–270 very (>270 days) post-COVID-19 recovery. Six while nine did so Data 14 (627 cases 694 controls) 15 (578 703 our meta-analysis. showed significant decrease to (standardized mean difference [SMD]= −2.02, p < 0.001), partial improvements noted recovery (SMD = 0.95, 0.001) 0.92, 0.006). Normalization observed 0.12, 0.69). In contrast, values, which higher than 1.27, remained elevated throughout F/U, no except (SMD= −0.39, 0.001). recovery, values those 0.45, 0.010). manuscript, we discuss how factors, severity COVID-19, persistence syndrome, patient’s initial vascular age, depending metrics age risk influenced time degree improvement.

Language: Английский

Citations

0

WNT Signaling Cascade Proteins and Structural and Functional State of The Vascular Bed in Patients With Various Phenotypes of Stable Ischemic Heart Disease DOI
A. O. Iusupova, N. N. Pakhtusov, O. А. Slepova

et al.

Kardiologiia, Journal Year: 2025, Volume and Issue: 65(3), P. 3 - 9

Published: March 31, 2025

Aim To evaluate the concentration of WNT signaling cascade proteins (WNT1, -3a, -4, -5a) and state vasculature by photoplethysmography (PPG) in patients with different phenotypes stable ischemic heart disease (IHD), obstructive non-obstructive coronary artery (CAD). Material methods This cross-sectional observational study included 80 (45-75 years old) a verified diagnosis IHD. Based on results angiography or multislice spiral computed tomography angiography, were divided into two equal groups (n=40), IHD (oIHD), ischemia no CAD angina (INOCA/ANOCA). In oIHD group, men prevailed (67.5%) while INOCA/ANOCA women (57.5%). Noninvasive PPG evaluation was performed, WNT1, -5a concentrations measured ELISA all patients. Results Higher WNT1 WNT3a found (p<0.001) group had significantly higher WNT5a (p=0.001). According to data, arterial stiffness index (aSI) differed between (7.6 m/s [6.6; 9.35]) (9.25 [7.88; 10.33]) groups, p=0.048). The correlation analysis revealed relationship reflectance RI (ρ=0.359; p=0.014) (oIHD+INOCA/ANOCA). ROC analysis, curve for turned out be diagnostically significant (sensitivity specificity model 85.7 87.0%, respectively). cut-off value 0.183 pg/ml. Conclusion showed that activation canonical (WNT1 WNT3a) observed oIHD, non-canonical (WNT5a) activated INOCA/ANOCA. phenotype can predicted ≥0.183

Language: Английский

Citations

0

Insights into the Risk Factors and Outcomes of Post-COVID-19 Syndrome—Results from a Retrospective, Cross-Sectional Study in Romania DOI Creative Commons
Ioana Bejan, Corneliu Petru Popescu, Simona Ruță

et al.

Life, Journal Year: 2024, Volume and Issue: 14(11), P. 1519 - 1519

Published: Nov. 20, 2024

Post-Coronavirus Disease 2019 (post-COVID-19) syndrome represents a cluster of persistent symptoms following Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection that can severely affect quality life. The pathogenic mechanisms and epidemiology in different regions are still under evaluation. To assess the outcomes post-COVID-19 syndrome, we performed questionnaire-based, cross-sectional study previously infected individuals. Out 549 respondents, (male:female ratio: 0.32), 29.5% had at 3 months, 23.5% 6 18.3% 12 months after initial infection. most common included fatigue (8.7%), sleep disturbances (7.1%), cognitive impairment (6.4%). risk developing increased for those with more acute phase (OR 4.24,

Language: Английский

Citations

0